Previous Article | Next Article 
Molecular and Cellular Biology, August 2000, p. 5690-5699, Vol. 20, No. 15
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Evidence for a Telomere-Independent "Clock"
Limiting RAS Oncogene-Driven Proliferation of Human Thyroid
Epithelial Cells
C. J.
Jones,1
D.
Kipling,1
M.
Morris,1
P.
Hepburn,1
J.
Skinner,1
A.
Bounacer,1
F. S.
Wyllie,1
M.
Ivan,1
J.
Bartek,2
D.
Wynford-Thomas,1,* and
J. A.
Bond1
Cancer Research Campaign Laboratories,
Department of Pathology, University of Wales College of Medicine, Heath
Park, Cardiff CF14 4XN, United Kingdom,1 and
Institute of Cancer Biology, Danish Cancer Society, DK-2100
Copenhagen, Denmark2
Received 9 December 1999/Returned for modification 3 January
2000/Accepted 27 April 2000
An initiating role for RAS oncogene mutation in several
epithelial cancers is supported by its high incidence in early-stage tumors and its ability to induce proliferation in the corresponding normal cells in vitro. Using retroviral transduction of thyroid epithelial cells as a model we ask here: (i) how mutant RAS can induce
long-term proliferation in an epithelial cell in contrast to the
premature senescence observed in fibroblasts; and (ii) what is the
"clock" which eventually triggers spontaneous growth arrest even in
epithelial clones generated by mutant RAS. The early response to
RAS activation in thyroid epithelial cells showed two
features not seen in fibroblasts: (i) a marked decrease in expression
of the cyclin-dependent kinase inhibitor (CDKI) p27kip1 and
(ii) the absence of any induction of p21waf1. When
proliferation eventually ceased (after up to 20 population doublings)
this occurred despite undiminished expression of mutant RAS and was
tightly correlated with a return to the initial high level of
p27kip1 expression, together with the de novo appearance of
p16ink4a. Importantly, neither the CDKI changes nor the
proliferative life span of RAS-induced epithelial clones was altered by
induction of telomerase activity through forced expression of the
catalytic subunit, hTERT, at levels sufficient to immortalize human
fibroblasts. These data provide a basis for cell-type differences in
sensitivity to RAS-induced proliferation which may explain the
corresponding tumor-type specificity of RAS mutation. They also show
for the first time in a primary human cell model that a
telomere-independent mechanism can limit not only physiological but
also oncogene-driven proliferation, pointing therefore to a tumour
suppressor mechanism additional, or alternative, to the telomere clock.
*
Corresponding author. Mailing address: Cancer Research
Campaign Laboratories, Department of Pathology, University of Wales College of Medicine, Heath Park, Cardiff CF14 4XN, United Kingdom. Phone: 44 (029) 2074 2700. Fax: 44 (029) 2074 2704. E-mail:
KingTD{at}Cardiff.ac.uk.
Molecular and Cellular Biology, August 2000, p. 5690-5699, Vol. 20, No. 15
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Paternot, S., Dumont, J. E., Roger, P. P.
(2006). Differential Utilization of Cyclin D1 and Cyclin D3 in the Distinct Mitogenic Stimulations by Growth Factors and TSH of Human Thyrocytes in Primary Culture. Mol. Endocrinol.
20: 3279-3292
[Abstract]
[Full Text]
-
Fikaris, A. J., Lewis, A. E., Abulaiti, A., Tsygankova, O. M., Meinkoth, J. L.
(2006). Ras Triggers Ataxia-telangiectasia-mutated and Rad-3-related Activation and Apoptosis through Sustained Mitogenic Signaling. J. Biol. Chem.
281: 34759-34767
[Abstract]
[Full Text]
-
Abulaiti, A., Fikaris, A. J., Tsygankova, O. M., Meinkoth, J. L.
(2006). Ras Induces Chromosome Instability and Abrogation of the DNA Damage Response. Cancer Res.
66: 10505-10512
[Abstract]
[Full Text]
-
Braig, M., Schmitt, C. A.
(2006). Oncogene-induced senescence: putting the brakes on tumor development.. Cancer Res.
66: 2881-2884
[Abstract]
[Full Text]
-
Shay, J. W., Wright, W. E.
(2005). Senescence and immortalization: role of telomeres and telomerase. Carcinogenesis
26: 867-874
[Abstract]
[Full Text]
-
Motti, M. L., Califano, D., Troncone, G., De Marco, C., Migliaccio, I., Palmieri, E., Pezzullo, L., Palombini, L., Fusco, A., Viglietto, G.
(2005). Complex Regulation of the Cyclin-Dependent Kinase Inhibitor p27kip1 in Thyroid Cancer Cells by the PI3K/AKT Pathway: Regulation of p27kip1 Expression and Localization. Am. J. Pathol.
166: 737-749
[Abstract]
[Full Text]
-
Sahin, M., Allard, B. L., Yates, M., Powell, J. G., Wang, X.-L., Hay, I. D., Zhao, Y., Goellner, J. R., Sebo, T. J., Grebe, S. K. G., Eberhardt, N. L., McIver, B.
(2005). PPAR{gamma} Staining as a Surrogate for PAX8/PPAR{gamma} Fusion Oncogene Expression in Follicular Neoplasms: Clinicopathological Correlation and Histopathological Diagnostic Value. J. Clin. Endocrinol. Metab.
90: 463-468
[Abstract]
[Full Text]
-
Kipling, D., Davis, T., Ostler, E. L., Faragher, R. G. A.
(2004). What Can Progeroid Syndromes Tell Us About Human Aging?. Science
305: 1426-1431
[Abstract]
[Full Text]
-
Benanti, J. A., Galloway, D. A.
(2004). Normal Human Fibroblasts Are Resistant to RAS-Induced Senescence. Mol. Cell. Biol.
24: 2842-2852
[Abstract]
[Full Text]
-
Evans, R. J., Wyllie, F. S., Wynford-Thomas, D., Kipling, D., Jones, C. J.
(2003). A P53-dependent, Telomere-independent Proliferative Life Span Barrier in Human Astrocytes Consistent with the Molecular Genetics of Glioma Development. Cancer Res.
63: 4854-4861
[Abstract]
[Full Text]
-
Nikiforova, M. N., Lynch, R. A., Biddinger, P. W., Alexander, E. K., Dorn, G. W. II, Tallini, G., Kroll, T. G., Nikiforov, Y. E.
(2003). RAS Point Mutations and PAX8-PPAR{gamma} Rearrangement in Thyroid Tumors: Evidence for Distinct Molecular Pathways in Thyroid Follicular Carcinoma. J. Clin. Endocrinol. Metab.
88: 2318-2326
[Abstract]
[Full Text]
-
Cheng, G., Lewis, A. E., Meinkoth, J. L.
(2003). Ras Stimulates Aberrant Cell Cycle Progression and Apoptosis in Rat Thyroid Cells. Mol. Endocrinol.
17: 450-459
[Abstract]
[Full Text]
-
Fagin, J. A.
(2002). Minireview: Branded from the Start--Distinct Oncogenic Initiating Events May Determine Tumor Fate in the Thyroid. Mol. Endocrinol.
16: 903-911
[Abstract]
[Full Text]
-
Peitl, P., Mello, S. S., Camparoto, M. L., Passos, G. A.S., Hande, M. P., Cardoso, R. S., Sakamoto-Hojo, E. T.
(2002). Chromosomal rearrangements involving telomeric DNA sequences in Balb/3T3 cells transfected with the Ha-ras oncogene. Mutagenesis
17: 67-72
[Abstract]
[Full Text]
-
Kimura, T., Van Keymeulen, A., Golstein, J., Fusco, A., Dumont, J. E., Roger, P. P.
(2001). Regulation of Thyroid Cell Proliferation by TSH and Other Factors: A Critical Evaluation of in Vitro Models. Endocr. Rev.
22: 631-656
[Abstract]
[Full Text]
-
Ramirez, R. D., Morales, C. P., Herbert, B.-S., Rohde, J. M., Passons, C., Shay, J. W., Wright, W. E.
(2001). Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions. Genes Dev.
15: 398-403
[Abstract]
[Full Text]
-
Stoeber, K., Tlsty, T. D., Happerfield, L., Thomas, G. A., Romanov, S., Bobrow, L., Williams, E. D., Williams, G. H.
(2001). DNA replication licensing and human cell proliferation. J. Cell Sci.
114: 2027-2041
[Abstract]
[Full Text]